Utpal Koppikar - Jun 8, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Financial Officer
Signature
/s/ David Tucker, Attorney-in-Fact for Utpal Koppikar
Stock symbol
ATRA
Transactions as of
Jun 8, 2021
Transactions value $
-$81,829
Form type
4
Date filed
6/9/2021, 04:06 PM
Previous filing
May 20, 2021
Next filing
Jul 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$81.8K -5.82K -3.41% $14.06* 165K Jun 8, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
F2 Includes 1,802 shares issued on May 28, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.